Three investment funds with holdings in Spanish drugmaker Grifols have teamed up to ask to fill a vacant seat on the company’s board, they said in a statement late on Thursday.
They said Grifols, which produces plasma-based medicines, had “an attractive growth profile” and its shares were undervalued and they wanted to make sure any takeover offer would include “a price that is fair for all shareholders”.
Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer: